RECINELLA DANIEL 4
4 · ANGIODYNAMICS INC · Filed Jul 12, 2005
Insider Transaction Report
Form 4
RECINELLA DANIEL
VP - Product Development
Transactions
- Sale
Common Stock
2005-07-11$25.00/sh−5,000$125,000→ 110 total - Exercise/Conversion
Common Stock
2005-07-11$4.35/sh+5,000$21,739→ 5,110 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2005-07-11−5,000→ 3,455 totalExercise: $4.35From: 2004-12-30Exp: 2007-03-04→ Common Stock (5,000 underlying)
Holdings
- 4,300
Non-Qualified Stock Option (right to buy)
Exercise: $10.64From: 2005-10-18Exp: 2014-10-18→ Common Stock (4,300 underlying) - 3,700
Non-Qualified Stock Option (right to buy)
Exercise: $13.18From: 2005-07-20Exp: 2014-07-20→ Common Stock (3,700 underlying) - 1,500
Restricted Stock Units
Exercise: $0.00From: 2009-05-30Exp: 2019-05-29→ Common Stock (1,500 underlying)
Footnotes (4)
- [F1]Transaction executed pursuant to an approved selling plan established under SEC rule 10b5-1.
- [F2]Options for 25% of the shares are each exercisable on 10/18/05, 10/18/06, 10/18/07, 10/18/08, respectively.
- [F3]Options for 25% of the shares are each exercisable on 7/20/05, 7/20/06, 7/20/07, 7/20/08, respectively.
- [F4]Each restricted stock unit represents a contingent right to receive one share of AngioDynamics, Inc. common stock.